Physician profile
Taylor P Mathis
NPI 1053622498
$3,774.46
in general payments reported to CMS, 2019-2025
28 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,524 · 2020: $253 · 2021: $222 · 2022: $242 · 2023: $253 · 2024: $93.90 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,322.50 | 2019 | |
| Gentleman Orthopedic Solutions | $885.65 | 2019-2023 | |
| Pacira Therapeutics, INC. | $285.59 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $214.62 | 2019-2023 | Xiaflex |
| Depuy Synthes Sales INC. | $158.38 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $120.07 | 2023-2025 | Iovera, Exparel, Zilretta |
| Stryker Corporation | $95.91 | 2022-2023 | Inspace |
| Bioventus LLC | $89.90 | 2019-2025 | Xcell |
| Innovation Technologies INC | $85.49 | 2023-2025 | Irrisept |
| Boston Scientific Corporation | $79.67 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Djo, LLC | $47.65 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $41.96 | 2022-2023 | Seglentis |
| Endo USA, INC. | $35.28 | 2025 | Xiaflex |
| Abbvie INC. | $33.70 | 2024-2025 | |
| Baxter Healthcare | $33.27 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $29.76 | 2019 | |
| Si-Bone, INC. | $28.59 | 2022-2023 | |
| Next Science LLC | $26.21 | 2021 | |
| Sanara Medtech INC. | $25.89 | 2021 | |
| Convatec INC. | $18.37 | 2019 | |
| Fidia Pharma USA INC. | $17.51 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.09 | 2019 | |
| Smith+Nephew, INC. | $15.83 | 2019 | |
| Abbott Laboratories | $14.62 | 2024 | Proclaim |
| Baudax Bio INC. | $14.39 | 2021 | |
| Horizon Therapeutics Plc | $13.05 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $12.70 | 2021 | |
| Medtronic USA, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.